Bioxyne Limited (ASX:BXN)
0.0550
-0.0010 (-1.79%)
Mar 13, 2026, 9:59 AM AEST
Bioxyne Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 7.6 | 7.67 | 1.03 | 3.85 | 0.07 | 1.6 |
Cash & Short-Term Investments | 7.6 | 7.67 | 1.03 | 3.85 | 0.07 | 1.6 |
Cash Growth | 183.80% | 645.88% | -73.27% | 5733.24% | -95.88% | -8.33% |
Accounts Receivable | 5.81 | 2.35 | 0.98 | 0.83 | 0.23 | 0.34 |
Other Receivables | 0.2 | 0.18 | 0.26 | 0.18 | 0.02 | 0.06 |
Receivables | 6.01 | 2.54 | 1.24 | 1.01 | 0.25 | 0.4 |
Inventory | 11.73 | 3.61 | 2.14 | 0.99 | 0.08 | 0.37 |
Prepaid Expenses | 3.34 | 0.87 | 0.76 | 0.19 | 0.01 | 0.12 |
Other Current Assets | - | 1.06 | 0.42 | 0 | 0 | 0.02 |
Total Current Assets | 28.69 | 15.74 | 5.59 | 6.04 | 0.4 | 2.51 |
Property, Plant & Equipment | 5.52 | 3.37 | 0.82 | 0.09 | 0.04 | 0.09 |
Goodwill | - | - | - | 11.57 | - | - |
Other Intangible Assets | 0.33 | - | - | - | - | 0.07 |
Long-Term Deferred Charges | - | 0.39 | 0.29 | - | - | - |
Other Long-Term Assets | 0.08 | 0.08 | - | - | - | - |
Total Assets | 34.63 | 19.58 | 6.7 | 17.69 | 0.45 | 2.68 |
Accounts Payable | 4.7 | 2.73 | 1.19 | 1.21 | 0.2 | 0.18 |
Accrued Expenses | 1.87 | 1.4 | 0.87 | 0.69 | 0.11 | 0.56 |
Short-Term Debt | 0.27 | - | 0.04 | 0.56 | 0.4 | - |
Current Portion of Long-Term Debt | 0.38 | 0.07 | - | - | - | - |
Current Portion of Leases | 0.56 | 0.4 | 0.18 | - | - | - |
Other Current Liabilities | 0.94 | 1.81 | 0.62 | 0.23 | 0.1 | 0.01 |
Total Current Liabilities | 10.3 | 6.4 | 2.91 | 2.69 | 0.82 | 0.74 |
Long-Term Debt | 2.09 | 0.28 | - | - | - | - |
Long-Term Leases | 2.06 | 0.79 | 0.49 | - | - | - |
Other Long-Term Liabilities | - | - | - | - | -0 | - |
Total Liabilities | 14.45 | 7.47 | 3.4 | 2.69 | 0.81 | 0.74 |
Common Stock | 22.21 | 21.48 | 19 | 17.55 | 0.13 | 62.18 |
Retained Earnings | -3.67 | -10.7 | -15.6 | -2.48 | -0.54 | -60.24 |
Comprehensive Income & Other | 1.62 | 1.63 | 0.21 | 0.07 | 0.05 | -0.06 |
Total Common Equity | 20.17 | 12.41 | 3.61 | 15.14 | -0.36 | 1.88 |
Minority Interest | - | -0.31 | -0.31 | -0.13 | - | 0.05 |
Shareholders' Equity | 20.17 | 12.1 | 3.3 | 15.01 | -0.36 | 1.93 |
Total Liabilities & Equity | 34.63 | 19.58 | 6.7 | 17.69 | 0.45 | 2.68 |
Total Debt | 5.37 | 1.53 | 0.71 | 0.56 | 0.4 | - |
Net Cash (Debt) | 2.24 | 6.13 | 0.32 | 3.29 | -0.33 | 1.6 |
Net Cash Growth | 136.51% | 1831.58% | -90.34% | - | - | -5.78% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 |
Filing Date Shares Outstanding | 2,225 | 2,172 | 2,047 | 1,902 | 640.15 | 640.15 |
Total Common Shares Outstanding | 2,225 | 2,165 | 2,047 | 1,902 | 640.15 | 640.15 |
Working Capital | 18.39 | 9.34 | 2.68 | 3.35 | -0.41 | 1.77 |
Book Value Per Share | 0.01 | 0.01 | 0.00 | 0.01 | -0.00 | 0.00 |
Tangible Book Value | 19.84 | 12.41 | 3.61 | 3.57 | -0.36 | 1.81 |
Tangible Book Value Per Share | 0.01 | 0.01 | 0.00 | 0.00 | -0.00 | 0.00 |
Machinery | 2.95 | 2.19 | 0.38 | - | 0.08 | 0.1 |
Leasehold Improvements | 0.85 | 0.61 | - | - | - | 0.05 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.